Quick Heal Technologies Schedules Q4 FY2025-26 Earnings Conference Call for May 22, 2026

1 min read     Updated on 18 May 2026, 03:33 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Quick Heal Technologies Limited has scheduled an earnings conference call for May 22, 2026, at 4:00 PM IST to discuss its Q4 and full-year FY2025-26 financial results. The call, hosted by Valorem Advisors, will feature Managing Director Dr. Kailash Katkar, Joint Managing Director Dr. Sanjay Katkar, and CFO Mr. Ankit Maheshwari. Dial-in access is available via universal and international toll-free numbers across the USA, UK, Singapore, and Hong Kong. The regulatory filing was submitted on May 18, 2026, by Compliance Officer Vikram Dhanani under reference number QHTL/Sec/SE/2026-27/07.

powered bylight_fuzz_icon
40644165

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited has announced an earnings conference call to discuss its financial results for Quarter 4 and the full Financial Year 2025-26. The call is scheduled for Friday, May 22, 2026, at 4:00 PM IST, and will be hosted by Valorem Advisors. The announcement was made through a regulatory filing dated May 18, 2026, submitted by Compliance Officer Vikram Dhanani.

Management Representation

The company's senior leadership team will represent Quick Heal Technologies during the earnings call. The following executives are confirmed to participate:

  • Dr. Kailash Katkar – Managing Director
  • Dr. Sanjay Katkar – Joint Managing Director
  • Mr. Ankit Maheshwari – Chief Financial Officer

Conference Call Access Details

Participants can join the call through multiple dial-in options. The following access details have been provided for the conference call:

Parameter: Details
Date: Friday, May 22, 2026
Time: 4:00 PM IST
Universal Dial-in: +91 22 6280 1341 / +91 22 7115 8242
USA Toll Free: 18667462133
UK Toll Free: 08081011573
Singapore Toll Free: 8001012045
Hong Kong Toll Free: 800964448
Investor Kit Link: https://valoremadvisors.com/quick

The dial-in numbers are accessible from all carriers. An investor kit link has also been made available for participants seeking additional information ahead of the call.

Regulatory Filing

The notice was filed with both BSE Limited and the National Stock Exchange of India Limited on May 18, 2026, in compliance with Regulation 30. The filing was signed by Vikram Dhanani, Compliance Officer of Quick Heal Technologies Limited, and carries reference number QHTL/Sec/SE/2026-27/07.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.40%-1.05%+19.48%-34.74%-30.32%-7.79%

How has Quick Heal Technologies' revenue mix between enterprise and consumer cybersecurity segments evolved in FY2025-26, and what growth trajectory is management projecting for FY2026-27?

Given the increasing competition from global cybersecurity players entering the Indian market, what strategic initiatives is Quick Heal planning to defend and expand its market share?

Will Quick Heal Technologies announce any guidance on potential acquisitions, partnerships, or new product launches in emerging areas like AI-driven threat detection or cloud security during the earnings call?

Quick Heal Technologies
View Company Insights
View All News
like20
dislike

Quick Heal Technologies Schedules Board Meeting on May 21, 2026 to Approve Q4 and Full-Year Audited Results

1 min read     Updated on 15 May 2026, 01:03 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Quick Heal Technologies has scheduled a board meeting for May 21, 2026, to consider and approve audited financial results — both standalone and consolidated — for the fourth quarter and year ended March 31, 2026. The intimation was issued on May 15, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015. The trading window close period commenced from April 01, 2026, and will end 48 hours after the financial results are made public on May 21, 2026.

powered bylight_fuzz_icon
40375983

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies has notified the stock exchanges of an upcoming board meeting, scheduled for Thursday, May 21, 2026. The intimation has been issued pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, and was communicated to both BSE Limited and the National Stock Exchange of India Limited on May 15, 2026.

Board Meeting Agenda

The board meeting will take up the following key business for consideration and approval:

  • Audited Financial Results (Standalone): For the fourth quarter and year ended March 31, 2026
  • Audited Financial Results (Consolidated): For the fourth quarter and year ended March 31, 2026

The following table summarises the key details of the scheduled board meeting:

Parameter: Details
Meeting Date: Thursday, May 21, 2026
Regulatory Reference: Regulation 29, SEBI (LODR), 2015
Results Period: Q4 and year ended March 31, 2026
Results Type: Standalone and Consolidated (Audited)
Intimation Date: May 15, 2026

Trading Window Closure

In accordance with the company's Code of Conduct for Prevention of Insider Trading in securities of the company, the trading window close period has been in effect since April 01, 2026. The trading window will remain closed until 48 hours after the financial results are made public on May 21, 2026.

The intimation was signed by Vikram Dhanani, Compliance Officer of Quick Heal Technologies, and has been submitted to the corporate services departments of both BSE Limited and the National Stock Exchange of India Limited for their information and records.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.40%-1.05%+19.48%-34.74%-30.32%-7.79%

How might Quick Heal Technologies' FY2026 annual results reflect the growing competition from global cybersecurity players entering the Indian market?

Will Quick Heal's board consider announcing a dividend or share buyback alongside the Q4 FY2026 results given the company's recent cash position?

How could Quick Heal's transition toward enterprise and B2B cybersecurity solutions impact its revenue growth trajectory in FY2027?

Quick Heal Technologies
View Company Insights
View All News
like17
dislike

More News on Quick Heal Technologies

1 Year Returns:-30.32%